Альманах клинической медицины. 2014; : 96-99
Перианальные кондиломы: клиника, диагностика, перспективы лечения
https://doi.org/10.18786/2072-0505-2014-34-96-99Аннотация
Список литературы
1. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005;191(2):182–92.
2. Кулаков ВИ, Савельева ГМ, Манухин ИБ, ред. Гинекология: национальное руководство. М.: ГЭОТАР-Медиа; 2007. 1072 с.
3. (Kulakov VI, Savel’evа GM, Manukhin IB, editors. Gynecology: national guideline. Moscow: GEOTAR-Media; 2007. 1072 р. Russian).
4. Дубенский ВВ, Максимов МО. Современный взгляд на диагностику и лечение урогенитальной папилломавирусной инфекции. Российский журнал кожных и венерических болезней. 2001;(1):51–6.
5. (Dubenskiy VV, Maksimov MO. [Modern approaches to the diagnosis and treatment of urogenital papillomavirus infection]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2001;(1):51–6. Russian).
6. Роговская С.И. Папилломавирусная инфекция и патология шейки матки. М.: ГЭОТАР-Медиа; 2009. 198 с.
7. (Rogovskaya S.I. Papillomavirus infection and disorders of uterine cervix. Moscow: GEOTAR-Media; 2009. 198 p. Russian).
8. Jansen KU, Shaw AR. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med. 2004;55:319–31.
9. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102(5A):3–8.
10. Rowhani-Rahbar A, Carter JJ, Hawes SE, Hughes JP, Weiss NS, Galloway DA, Koutsky LA. Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines. J Infect Dis. 2009;200(9):1452–5.
11. Tortolero-Luna G. Epidemiology of genital human papillomavirus. Hematol Oncol Clin North Am. 1999;13(1):245–57.
12. Статистические материалы: заболеваемость, ресурсы и деятельность кожно-венерологических учреждений в 2008– 2009 гг. М.; 2010. 119 с.
13. (Disease incidence, resources and activities of dermatovenerological facilities: statistics 2008–2009. Moscow; 2010. 119 р. Russian).
14. Palefsky J. Efficacy of the quadrivalent HPV vaccine to prevent anal intraepithelial neoplasia among young men who have sex with men. 26th International Papillomavirus Conference; July 3–8 2010; Montreal, Canada. 2010.
15. Dunne EF, Markowitz LE, Hariri S, Datta D, Saraiya M, Unger ER. Strategies to monitor HPV vaccine impact in USA. Abstracts, 25 HPV conference. Sweeden 2009; 2701.
16. Franco L, Villa L, Richardson H. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. In: Franco EL, Monsonego J, editors. New developments in cervical cancer screening and prevention. Oxford: Blackwell Science; 1997. p. 14–22.
17. Soper DE. Genitourinary infections and sexually transmitted diseases. In: Berek J, editor. Novak’s Gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 453–70.
18. Bosch F, Gissman L, Kocken M. European Consensus Statement on “HPV Vaccination and Colposcopy” Prepared on behalf of the European Federation for Colposcopy. EFC conference. Berlin; 2010. p. 97–100.
19. Аруин ЛИ, Капуллер ЛЛ, Исаков ВА. Морфологическая диагностика болезней желудка и кишечника. М.: Триада-Х; 1998. 496 c. (Aruin LI, Kapuller LL, Isakov VA. Morphological diagnosis of gastric and intestinal diseases. Moscow: Triada-Х; 1998. Russian).
20. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health. 2004;36(1):11–9.
21. Sexually transmitted infections quarterly report: Anogenital warts and HSV infection in England and Wales. CDR Wkly. 2001;11(35): 546–8.
22. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002;35(Suppl 2):S210–24.
23. Brotherton J, Fridman M, Saville M, Gertig D. First indication of a possible impact on cervical abnormalities following a national HPV vaccination program in Victoria, Australia. Updated July 2010. Abstract # 508, presented at IPV 2010, Montreal.
Almanac of Clinical Medicine. 2014; : 96-99
PERIANAL CONDYLOMAS: CLINICAL SYMPTOMS, DIAGNOSIS AND TREATMENT OPPORTUNITIES
https://doi.org/10.18786/2072-0505-2014-34-96-99Abstract
References
1. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005;191(2):182–92.
2. Kulakov VI, Savel'eva GM, Manukhin IB, red. Ginekologiya: natsional'noe rukovodstvo. M.: GEOTAR-Media; 2007. 1072 s.
3. (Kulakov VI, Savel’eva GM, Manukhin IB, editors. Gynecology: national guideline. Moscow: GEOTAR-Media; 2007. 1072 r. Russian).
4. Dubenskii VV, Maksimov MO. Sovremennyi vzglyad na diagnostiku i lechenie urogenital'noi papillomavirusnoi infektsii. Rossiiskii zhurnal kozhnykh i venericheskikh boleznei. 2001;(1):51–6.
5. (Dubenskiy VV, Maksimov MO. [Modern approaches to the diagnosis and treatment of urogenital papillomavirus infection]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2001;(1):51–6. Russian).
6. Rogovskaya S.I. Papillomavirusnaya infektsiya i patologiya sheiki matki. M.: GEOTAR-Media; 2009. 198 s.
7. (Rogovskaya S.I. Papillomavirus infection and disorders of uterine cervix. Moscow: GEOTAR-Media; 2009. 198 p. Russian).
8. Jansen KU, Shaw AR. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med. 2004;55:319–31.
9. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102(5A):3–8.
10. Rowhani-Rahbar A, Carter JJ, Hawes SE, Hughes JP, Weiss NS, Galloway DA, Koutsky LA. Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines. J Infect Dis. 2009;200(9):1452–5.
11. Tortolero-Luna G. Epidemiology of genital human papillomavirus. Hematol Oncol Clin North Am. 1999;13(1):245–57.
12. Statisticheskie materialy: zabolevaemost', resursy i deyatel'nost' kozhno-venerologicheskikh uchrezhdenii v 2008– 2009 gg. M.; 2010. 119 s.
13. (Disease incidence, resources and activities of dermatovenerological facilities: statistics 2008–2009. Moscow; 2010. 119 r. Russian).
14. Palefsky J. Efficacy of the quadrivalent HPV vaccine to prevent anal intraepithelial neoplasia among young men who have sex with men. 26th International Papillomavirus Conference; July 3–8 2010; Montreal, Canada. 2010.
15. Dunne EF, Markowitz LE, Hariri S, Datta D, Saraiya M, Unger ER. Strategies to monitor HPV vaccine impact in USA. Abstracts, 25 HPV conference. Sweeden 2009; 2701.
16. Franco L, Villa L, Richardson H. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. In: Franco EL, Monsonego J, editors. New developments in cervical cancer screening and prevention. Oxford: Blackwell Science; 1997. p. 14–22.
17. Soper DE. Genitourinary infections and sexually transmitted diseases. In: Berek J, editor. Novak’s Gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 453–70.
18. Bosch F, Gissman L, Kocken M. European Consensus Statement on “HPV Vaccination and Colposcopy” Prepared on behalf of the European Federation for Colposcopy. EFC conference. Berlin; 2010. p. 97–100.
19. Aruin LI, Kapuller LL, Isakov VA. Morfologicheskaya diagnostika boleznei zheludka i kishechnika. M.: Triada-Kh; 1998. 496 c. (Aruin LI, Kapuller LL, Isakov VA. Morphological diagnosis of gastric and intestinal diseases. Moscow: Triada-Kh; 1998. Russian).
20. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health. 2004;36(1):11–9.
21. Sexually transmitted infections quarterly report: Anogenital warts and HSV infection in England and Wales. CDR Wkly. 2001;11(35): 546–8.
22. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002;35(Suppl 2):S210–24.
23. Brotherton J, Fridman M, Saville M, Gertig D. First indication of a possible impact on cervical abnormalities following a national HPV vaccination program in Victoria, Australia. Updated July 2010. Abstract # 508, presented at IPV 2010, Montreal.
